Confused by distributed systems, blockchains and cryptography? Understand the technologies revolutionizing pharmaceuticals.
FALLS CHURCH, Va., July 16, 2020 /PRNewswire-PRWeb/ — Blockchain Systems in Pharmaceuticals
Transform Quality and Compliance
An FDAnews Webinar
Thursday, July 30, 2020, 1:30-3:30 p.m. EDT
https://www.fdanews.com/blockchainsystems
Blockchains are revolutionizing the pharmaceutical industry, simplifying existing processes for data integrity. These secure databases keep track of all transactions — concept, pre-clinical testing, phase I, II, III trials, approvals, postmarket surveillance, drug supply chain — in a single system.
To stay competitive, one needs to understand the core tenets of distributed systems, blockchains and cryptography. James Canterbury — a partner in Ernst & Young’s Risk Advisory practice where he works with the global blockchain team — will lay the foundation to leverage these systems:
- Highlights of where blockchains are currently being used in the pharmaceutical industry, including manufacturing and the supply chain
- The core components of blockchain technology, including single-source data integrity
- Public vs. private blockchains and the challenges, advantages and disadvantages of each
- How to use a blockchain as a notarization system
- The role of non-fungible tokens in product track and trace in the COVID-19 era and beyond
Put blockchain to work for teh company to streamline processes, improve quality, ensure compliance and simplify data integrity.
Interested in registering multiple sites?
Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally
to learn about our special multisite discount.
Webinar Details:
Blockchain Systems in Pharmaceuticals
Transform Quality and Compliance
An FDAnews Webinar
Thursday, July 30, 2020, 1:30-3:30 p.m. EDT
https://www.fdanews.com/blockchainsystems
Tuition:
$287 per site
Easy Ways to Register:
Online: https://www.fdanews.com/blockchainsystems
By phone: 888.838.5578 or 703.538.7600
About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews’ print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA’s complex and ever-changing regulations
SOURCE FDAnews